Condition category
Cancer
Date applied
01/07/2001
Date assigned
01/07/2001
Last edited
25/04/2008
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr - -

ORCID ID

Contact details

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

NCT00006231

Protocol/serial number

L52

Study information

Scientific title

Acronym

Study hypothesis

Not provided at time of registration

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Not Specified

Patient information sheet

Condition

Mesothelioma

Intervention

Arm 1: XRT: (21 Gy in 7 Gy fraction over 2 days)
Arm 2: No XRT

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall trial start date

19/02/1998

Overall trial end date

31/12/2002

Reason abandoned

Eligibility

Participant inclusion criteria

1. Tissue proven malignant pleural mesothelioma after chest drain, pleural biopsy and/or thoracoscopy
2. The invasive procedure should have occurred no more than 21 days previously
3. Informed consent

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

19/02/1998

Recruitment end date

31/12/2002

Locations

Countries of recruitment

United Kingdom

Trial participating centre

UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom

Sponsor information

Organisation

Cancer Research UK (CRUK) (UK)

Sponsor details

PO Box 123
Lincoln's Inn Fields
London
WC2A 3PX
United Kingdom
+44 (0)207 317 5186
kate.law@cancer.org.uk

Sponsor type

Charity

Website

http://www.cancer.org.uk

Funders

Funder type

Charity

Funder name

Cancer Research UK

Alternative name(s)

CRUK

Funding Body Type

private sector organisation

Funding Body Subtype

other non-profit

Location

United Kingdom

Funder name

West of Scotland Lung Cancer Group

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2007 results on http://www.ncbi.nlm.nih.gov/pubmed/17588698

Publication citations

  1. Results

    O'Rourke N, Garcia JC, Paul J, Lawless C, McMenemin R, Hill J, A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma., Radiother Oncol, 2007, 84, 1, 18-22, doi: 10.1016/j.radonc.2007.05.022.

Additional files

Editorial Notes